Gates Foundation’s Zymergen Inc. Common Stock ZY Stock Holding History

Gates Foundation’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-59,970	Closed	-$200K	–	10
2022 Q3	$200K	Hold	59,970	–	–	0.16%	10
2022 Q2	$100K	Hold	59,970	–	–	0.08%	9
2022 Q1	$200K	Hold	59,970	–	–	0.11%	11
2021 Q4	$400K	Hold	59,970	–	–	0.12%	11
2021 Q3	$800K	Hold	59,970	–	–	0.23%	10
2021 Q2	$2M	Buy	+59,970	New	+$2.37M	0.31%	8

Gates Foundation's ZY Position: Q4 2022 in Review

Gates Foundation sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 59,970 shares — an estimated $200K sold.

Gates Foundation first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $2M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Gates Foundation reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Gates Foundation sold 59,970 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $200K.
Gates Foundation first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Gates Foundation's Zymergen Inc. Common Stock position peaked at $2M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Gates Foundation's 13F filing for Q4 2022, filed 14 Feb 2023.